Cargando…

Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease

BACKGROUND: Elderly adults should avoid medications with anticholinergic effects since they may increase the risk of adverse events, including falls, delirium, and cognitive impairment. However, data on anticholinergic burden are limited in subpopulations, such as individuals with Parkinson disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crispo, James A. G., Willis, Allison W., Thibault, Dylan P., Fortin, Yannick, Hays, Harlen D., McNair, Douglas S., Bjerre, Lise M., Kohen, Dafna E., Perez-Lloret, Santiago, Mattison, Donald R., Krewski, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777375/ https://www.ncbi.nlm.nih.gov/pubmed/26939130 http://dx.doi.org/10.1371/journal.pone.0150621

Ejemplares similares

Trends in inpatient antiparkinson drug use in the USA, 2001–2012
por: Crispo, James A. G., et al.
Publicado: (2015)

Association between medication-related adverse events and non-elective readmission in acute ischemic stroke
por: Crispo, James A. G., et al.
Publicado: (2018)

Systemic quinolones and risk of acute liver failure III: A nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2021)

Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2022)

External validation and comparison of two variants of the Elixhauser comorbidity measures for all-cause mortality
por: Fortin, Yannick, et al.
Publicado: (2017)

Risk of Adverse Cardiovascular Events Following a Myocardial Infarction in Patients Receiving Combined Clopidogrel and Proton Pump Inhibitor Treatment: A Nested Case–Control Study
por: Farhat, Nawal, et al.
Publicado: (2020)

Inpatient care for stiff person syndrome in the United States: a nationwide readmission study
por: Crispo, James A. G., et al.
Publicado: (2018)

Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review
por: Salahudeen, Mohammed Saji, et al.
Publicado: (2015)

Systemic quinolones and risk of acute liver failure I: Analysis of data from the US FDA adverse event reporting system
por: Taher, Mohamed Kadry, et al.
Publicado: (2021)

Anticholinergic Burden of Geriatric Ward Inpatients
por: Wilczyński, Krzysztof, et al.
Publicado: (2021)

The anticholinergic burden: from research to practice
por: Hilmer, Sarah N, et al.
Publicado: (2022)

Anticholinergic Burden and Most Common Anticholinergic-acting Medicines in Older General Practice Patients
por: Gorup, Eva, et al.
Publicado: (2018)

Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study
por: Krüger, Caroline, et al.
Publicado: (2021)

Anticholinergic burden risk and prevalence of medications carrying anticholinergic properties in elderly cancer patients in Jordan
por: Al-Azayzih, Ahmad, et al.
Publicado: (2023)

Off-label use of cancer therapies in women diagnosed with breast cancer in the United States
por: Hamel, Sophie, et al.
Publicado: (2015)

High anticholinergic burden at admission associated with in‐hospital mortality in older patients: A comparison of 19 different anticholinergic burden scales
por: Lisibach, Angela, et al.
Publicado: (2021)

Evaluation of the association of anticholinergic burden and delirium in older hospitalised patients – A cohort study comparing 19 anticholinergic burden scales
por: Lisibach, Angela, et al.
Publicado: (2022)

Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
por: Alami, Abdallah, et al.
Publicado: (2022)

An anticholinergic burden score for German prescribers: score development
por: Kiesel, Esther Katharina, et al.
Publicado: (2018)

Consistency between anticholinergic burden scales in the elderly with fractures
por: Valladales-Restrepo, Luis Fernando, et al.
Publicado: (2020)

The evaluation of relationship between polypharmacy and anticholinergic burden scales
por: Okudur, Saadet Koc, et al.
Publicado: (2021)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2022)

Association between anticholinergic burden and dementia in UK Biobank
por: Mur, Jure, et al.
Publicado: (2021)

Development of the Swedish anticholinergic burden scale (Swe-ABS)
por: Rube, Tanja, et al.
Publicado: (2023)

Serum Anticholinergic Activity: A Possible Peripheral Marker of the Anticholinergic Burden in the Central Nervous System in Alzheimer's Disease
por: Hori, Koji, et al.
Publicado: (2014)

Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale
por: Suh, Yewon, et al.
Publicado: (2020)

Parkinson Disease Associated Differences in Elective Orthopedic Surgery Outcomes: A National Readmissions Database Analysis
por: Fullard, Michelle, et al.
Publicado: (2020)

The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia
por: Ang, Mei San, et al.
Publicado: (2017)

Anticholinergic Burden and Fractures: A Systematic Review with Methodological Appraisal
por: Reinold, Jonas, et al.
Publicado: (2020)

Measuring cumulative anticholinergic medicines burden in older Australian women
por: Parkinson, Lynne, et al.
Publicado: (2017)

Association between Anticholinergic Burden and Constipation: A Systematic Review
por: Rodríguez-Ramallo, Héctor, et al.
Publicado: (2021)

Assessing the Anticholinergic Burden in the West Memory Assessment Service (MAS)
por: Lees, Rebecca, et al.
Publicado: (2022)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis
por: Alami, Abdallah, et al.
Publicado: (2023)

Myocarditis and Pericarditis Post-mRNA COVID-19 Vaccination: Insights from a Pharmacovigilance Perspective
por: Alami, Abdallah, et al.
Publicado: (2023)

CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints
por: Ramos, Hernán, et al.
Publicado: (2022)

Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale – a healthcare improvement study in a geriatric ward setting
por: Balasundaram, Bharathi, et al.
Publicado: (2022)

Barriers and facilitators to reducing anticholinergic burden: a qualitative systematic review
por: Stewart, Carrie, et al.
Publicado: (2021)

Effects of Anticholinergic Burden on Verbal Memory Performance in First-Episode Psychosis
por: Belkacem, Agnès, et al.
Publicado: (2023)

Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study—study protocol
por: Dweik, Rania Al, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ufmfb9r0tavhbe0kpmt9418hsn